Cytek Biosciences Inc
Open
SectorHealthcare
4.3 -6.32
Overview
Share price change
24h
Min
4.3
Max
4.59
Income | -39M -44M |
|---|---|
Sales | 9.8M 62M |
Profit margin | -70.929 |
Employees | 702 |
EBITDA | 4M -263K |
Recommendations | Buy |
|---|---|
12 Months Forecast | +35.57% upside |
Next Earnings | 5 Aug 2026 |
|---|
Market Cap | 40M 602M |
|---|---|
Previous open | 10.62 |
Previous close | 4.3 |
News Sentiment
By Acuity
50%
50%
153 / 347 Healthcare
Technical Score
By Trading Central
Confidence
Weak Bullish Evidence
Cytek Biosciences Inc Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Cytek Biosciences Inc Forecast
Price Target
By TipRanks
12 Months Forecast
Average 6.25 USD 35.57%
High 7.5 USD
Low 5 USD
Based on 2 Wall Street analysts offering 12 month price targets forCytek Biosciences Inc - Dist in the last 3 months.
Sentiment
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$